![](https://webarchive.library.unt.edu/eot2008/20090514044212im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514044212im_/http://www.cancer.gov/images/spacer.gif)
| A substance being studied in the treatment of several types of cancer. It blocks the action of certain enzymes involved in cell growth and the repair of DNA damaged by some anticancer drugs. It is a type of tyrosine kinase inhibitor and a type of recombinase inhibitor. |
Previous Definitions: | mouse model, moxibustion, moxifloxacin, moxifloxacin hydrochloride, Mozobil | Next Definitions: | MPNST, MRI, MRSI, MS 209, MS-275 |
|
![](https://webarchive.library.unt.edu/eot2008/20090514044212im_/http://www.cancer.gov/images/spacer.gif) |